Anixa Biosciences Inc (ANIX)

Anixa Biosciences Inc (ANIX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $101M; returns 1 day +7.6%, 1 week +12.0%, 1 year -28.5%.

Anixa Biosciences, Inc. (ANIX) is a clinical-stage biotechnology company focused on developing therapies and vaccines for unmet needs in oncology and infectious diseases. As of January 2026, Anixa does not generate revenue from product sales and relies on equity financing and grants to fund its research and development.

Groups ANIX belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Oncology
• Immunotherapy
• Breast Cancer Treatment
• Ovarian Cancer
• Clinical Stage
• R&D
• Early Cancer Detection
• Infectious Diseases

ANIX financial model: income statement, cash flow and balance sheet